COVID-19 patients with elevated C-reactive protein, lymphopenia, or increased lactate dehydrogenase may need intensive care. Laboratory findings are important for interpreting and managing patient care.

Testing the inclusion of laboratory parameters in blood samples to improve the accuracy of COVID-19 diagnosis using rapid antigen tests (RAT) was investigated. Results showed that combining laboratory parameters with RAT results can enhance the identification of COVID-19 patients.

375 SARS-CoV-2-positive pregnant women and their neonates were evaluated from various studies conducted between December 2019 and July 2020. The information extracted included study details, maternal and infant characteristics, blood assays, and vertical transmission of COVID-19.

Recovery was achieved in more than half of the lung cancer patients with COVID-19, including those who required intubation. Multiple data sources were used to identify the patients.

Genetic factors influence antibody responses after vaccination, as seen in previous studies on other vaccines. A new study examines the genetic variation in COVID-19 vaccine responses.

PCT release is induced by bacterial infections, not viral infections. In our institution, PCT testing is restricted to intensive care units and requires approval from laboratory specialists in other wards.

Several studies have found genetic regulators of platelet count and size. Platelet immaturity has a distinct transcriptome.

The 4CE Consortium formed to collect electronic health record data from hospitals in four countries to study COVID-19. They evaluate if models trained in one country can be used elsewhere.

A study analyzed the lab results of COVID-19 positive and negative patients. COVID-19 positive patients had changes in 66 lab tests, higher fibrinogen, lower platelets, and 101 developed blood clots.

TWAS identifies 27 genes associated with COVID-19 hospitalization.